Press Releases

Bio-Techne To Acquire Exosome Diagnostics, Inc

exosomes

Bio-Techne Corporation announced today that it has reached agreement to acquire Exosome Diagnostics, Inc. for $250 million in cash plus contingent consideration of up to $325 million due upon the achievement of certain future milestones. The transaction is expected to ...

Read More »

Texas A&M researchers to investigating potential therapies for Alzheimer’s disease using MSC-derived exosomes

exosomes

Houston-based biotechnology company, Celltex Therapeutics Corporation, and Texas A&M University Health Science Center College of Medicine Institute for Regenerative Medicine announced an intellectual property license acquisition and research agreement. The announcement signals the first year of a multi-year research study investigating potential therapies ...

Read More »